Clinical trial
Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure
NCT04679597 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure
- Lead sponsor
- Institute of Oncology Ljubljana
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- December 31, 2019
- Enrollment
- 161 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer